Bristol-Myers Squibb Company (NYSE:BMY) and Meso Scale Discovery today announced they have entered an agreement to develop diagnostic assays that will measure cerebrospinal fluid biomarkers for use in Alzheimer’s disease research.
Original post:
... continue reading
SOUTH SAN FRANCISCO, Calif., Jan. 26, 2012 /PRNewswire/ – Janssen Alzheimer Immunotherapy, together with its collaborator on the Alzheimer's Immunotherapy Program (AIP), Pfizer Inc. (NYSE: PFE – News), and the …
Read the rest here:
Alzheimer's Challenge 2012: ... continue reading
CHICAGO and NEW YORK, Dec. 6, 2010 /PRNewswire/ — With as many as 10 million U.S. baby boomers at risk for developing Alzheimer’s,(1) the Alzheimer’s Association and Pfizer (NYSE: PFE) are collaborating to help raise awareness of Alzheimer’s disease by emphasizing to all Americans, “It’s Time to Face Alzheimer’s.” The ... continue reading